Spontaneous hemorrhage after the TricValve procedure

    Authors

    Keywords

    blood coagulation disorders, liver cirrhosis, tricuspid valve insufficiency

    DOI

    https://doi.org/10.15836/ccar2024.467

    Full Text

    **Introduction**: In patients with severe tricuspid insufficiency who are not candidates for surgery due to age or comorbidities, caval valve implantation (CAVI) has been available recently as a therapeutic option (1). Two valves are implanted in the upper and lower vena cava to reduce the symptoms of right-sided heart failure. Patients with liver cirrhosis are prone to bleeding complications, especially abdominal, due to portal hypertension and coagulopathy (2). **Case report**: 81-year-old woman with chronic heart failure, secondary pulmonary hypertension, permanent atrial fibrillation and severe tricuspid insufficiency was admitted to the Clinic for planned CAVI. In addition, the patient has cardiac cirrhosis and ischemic heart disease. The necessary image processing was done pre-procedurally, and the patient had no contraindications (EFLV >45%, Child-Pugh Score B, NYHA III, RSVP 55mmHg, TAPSE >13mm). The patient was anticoagulated with intravenous heparin during the procedure, and target ACT values were >250. A control venogram did not reveal a significant paravalvular leak. At the puncture site of the right femoral vein, hemostasis was achieved using a combination of a closure device and a “Z” suture. On the left side, hemostasis was achieved by manual compression. The early post-procedural course was complicated by left paraumbilical swelling of the abdominal wall, severe pain, hypotension and a significant drop in the red blood count. Urgent MSCT of the abdomen and pelvis verified an extensive extraperitoneal hematoma in the pelvic area and large intramuscular hematomas of both rectus abdominis muscles. Immediate exploratory laparotomy was performed, which showed no active bleeding from puncture sites. Hematomas were evacuated, and both femoral veins were sutured. The patient was sedated and mechanically ventilated and underwent standard treatment for hemorrhagic shock. A “second look” surgery was carried out three days later, and no active bleeding was found. Unfortunately, further hemodynamic instability ensued, and the patient died five days after the procedure. **Conclusion**: In patients with severe tricuspid insufficiency and cirrhosis-related coagulopathy, standard intraprocedural anticoagulation for CAVI and postprocedural venous blood pressure rise can lead to severe spontaneous intra-abdominal bleeding (3).

    Literature

    1. Sharma NK, Chouhan NS, Bansal M, Chandra P, Singh A, Juneja R. Heterotopic caval valve implantation in severe tricuspid regurgitation. Ann Card Anaesth. 2021 July-September;24(3):365–8. https://doi.org/10.4103/aca.ACA_72_20
    2. Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J, et al. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost. 2021 April;19(4):1116–22. https://doi.org/10.1111/jth.15239
    3. McCarthy DM, Bellam S. Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis. J Emerg Trauma Shock. 2010 July;3(3):300. https://doi.org/10.4103/0974-2700.66550
    Cardiologia Croatica
    Back to search

    Spontaneous hemorrhage after the TricValve procedure

    Extended Abstract
    Issue11-12
    Published
    Pages467
    PDF via DOIhttps://doi.org/10.15836/ccar2024.467
    blood coagulation disorders
    liver cirrhosis
    tricuspid valve insufficiency

    Authors

    Nikola VerunicaORCIDZadar General Hospital, Zadar, Croatia
    Ivana Smoljan*ORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Gordana BačićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Josip AničićUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Davorka LulićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Nikola PavlovićUniversity Hospital Centre Rijeka, Rijeka, Croatia
    Vjekoslav TomulićORCIDUniversity Hospital Centre Rijeka, Rijeka, Croatia

    *Correspondence email: ismoljan@yahoo.com

    Full Text

    Introduction: In patients with severe tricuspid insufficiency who are not candidates for surgery due to age or comorbidities, caval valve implantation (CAVI) has been available recently as a therapeutic option (1). Two valves are implanted in the upper and lower vena cava to reduce the symptoms of right-sided heart failure. Patients with liver cirrhosis are prone to bleeding complications, especially abdominal, due to portal hypertension and coagulopathy (2).

    Case report: 81-year-old woman with chronic heart failure, secondary pulmonary hypertension, permanent atrial fibrillation and severe tricuspid insufficiency was admitted to the Clinic for planned CAVI. In addition, the patient has cardiac cirrhosis and ischemic heart disease. The necessary image processing was done pre-procedurally, and the patient had no contraindications (EFLV >45%, Child-Pugh Score B, NYHA III, RSVP 55mmHg, TAPSE >13mm). The patient was anticoagulated with intravenous heparin during the procedure, and target ACT values were >250. A control venogram did not reveal a significant paravalvular leak. At the puncture site of the right femoral vein, hemostasis was achieved using a combination of a closure device and a “Z” suture. On the left side, hemostasis was achieved by manual compression. The early post-procedural course was complicated by left paraumbilical swelling of the abdominal wall, severe pain, hypotension and a significant drop in the red blood count. Urgent MSCT of the abdomen and pelvis verified an extensive extraperitoneal hematoma in the pelvic area and large intramuscular hematomas of both rectus abdominis muscles. Immediate exploratory laparotomy was performed, which showed no active bleeding from puncture sites. Hematomas were evacuated, and both femoral veins were sutured. The patient was sedated and mechanically ventilated and underwent standard treatment for hemorrhagic shock. A “second look” surgery was carried out three days later, and no active bleeding was found. Unfortunately, further hemodynamic instability ensued, and the patient died five days after the procedure.

    Conclusion: In patients with severe tricuspid insufficiency and cirrhosis-related coagulopathy, standard intraprocedural anticoagulation for CAVI and postprocedural venous blood pressure rise can lead to severe spontaneous intra-abdominal bleeding (3).

    Literature

    1. 1.
      Sharma NK, Chouhan NS, Bansal M, Chandra P, Singh A, Juneja R. Heterotopic caval valve implantation in severe tricuspid regurgitation. Ann Card Anaesth. 2021 July-September;24(3):365–8.DOI
    2. 2.
      Lisman T, Hernandez-Gea V, Magnusson M, Roberts L, Stanworth S, Thachil J, et al. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease. J Thromb Haemost. 2021 April;19(4):1116–22.DOI
    3. 3.
      McCarthy DM, Bellam S. Fatal spontaneous rectus sheath hematoma in a patient with cirrhosis. J Emerg Trauma Shock. 2010 July;3(3):300.DOI